Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunity.
Rossi, G A
Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunity. [electronic resource] - The American review of respiratory disease Apr 1987 - 885-90 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0003-0805
10.1164/arrd.1987.135.4.885 doi
Adjuvants, Immunologic--therapeutic use
Bacterial Vaccines
Corynebacterium
Female
Humans
Immunity, Cellular
Immunotherapy
Interferons--analysis
Killer Cells, Natural--immunology
Lung Neoplasms--complications
Male
Middle Aged
Monocytes--immunology
Pleura--immunology
Pleural Effusion--etiology
Propionibacterium acnes
Recurrence
T-Lymphocytes--classification
Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunity. [electronic resource] - The American review of respiratory disease Apr 1987 - 885-90 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0003-0805
10.1164/arrd.1987.135.4.885 doi
Adjuvants, Immunologic--therapeutic use
Bacterial Vaccines
Corynebacterium
Female
Humans
Immunity, Cellular
Immunotherapy
Interferons--analysis
Killer Cells, Natural--immunology
Lung Neoplasms--complications
Male
Middle Aged
Monocytes--immunology
Pleura--immunology
Pleural Effusion--etiology
Propionibacterium acnes
Recurrence
T-Lymphocytes--classification